Page last updated: 2024-08-16

risperidone and rm-493

risperidone has been researched along with rm-493 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arnold, AG; Birnbaum, SG; Chen, X; Jia, L; Li, L; Li, X; Liu, C; Sohn, JW; Wan, R; Wyler, SC; Yoo, ES	1

Other Studies

1 other study(ies) available for risperidone and rm-493

Article	Year
The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain. The Journal of experimental medicine, 2021, 07-05, Volume: 218, Issue:7 Topics: alpha-MSH; Animals; Antipsychotic Agents; Female; Hyperphagia; Hypothalamus; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Models, Animal; Neurons; Obesity; Olanzapine; Potassium; Receptor, Melanocortin, Type 4; Risperidone; Synaptic Potentials; Transcriptome; Weight Gain	2021

Article

Year

The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain.

The Journal of experimental medicine, 2021, 07-05, Volume: 218, Issue:7

Topics: alpha-MSH; Animals; Antipsychotic Agents; Female; Hyperphagia; Hypothalamus; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Models, Animal; Neurons; Obesity; Olanzapine; Potassium; Receptor, Melanocortin, Type 4; Risperidone; Synaptic Potentials; Transcriptome; Weight Gain

2021